Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study.

Filosso PL, Galassi C, Ruffini E, Margaritora S, Bertolaccini L, Casadio C, Anile M, Venuta F.

Eur J Cardiothorac Surg. 2013 Aug;44(2):219-24; discussion 224. doi: 10.1093/ejcts/ezs663. Epub 2013 Jan 11.

PMID:
23315959
2.

Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patients.

Filosso PL, Venuta F, Oliaro A, Ruffini E, Rendina EA, Margaritora S, Casadio C, Terzi A, Rena O, Lococo F, Guerrera F.

Eur J Cardiothorac Surg. 2014 Jun;45(6):1020-7. doi: 10.1093/ejcts/ezt567. Epub 2014 Jan 23.

3.

Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis.

López-Cano M, Ponseti-Bosch JM, Espin-Basany E, Sánchez-García JL, Armengol-Carrasco M.

Ann Thorac Surg. 2003 Nov;76(5):1643-9; discussion 1649.

PMID:
14602301
4.

Extrathymic malignancies in thymoma patients with and without myasthenia gravis.

Owe JF, Cvancarova M, Romi F, Gilhus NE.

J Neurol Sci. 2010 Mar 15;290(1-2):66-9. doi: 10.1016/j.jns.2009.11.006. Epub 2010 Jan 19.

PMID:
20034637
5.

Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A Retrospective clinicopathological multicentre analysis on 797 patients.

Filosso PL, Evangelista A, Ruffini E, Rendina EA, Margaritora S, Novellis P, Rena O, Casadio C, Andreetti C, Guerrera F, Lausi PO, Diso D, Mussi A, Venuta F, Oliaro A, Lucchi M.

Lung Cancer. 2015 Jun;88(3):338-43. doi: 10.1016/j.lungcan.2015.03.007. Epub 2015 Mar 14.

6.

Extrathymic malignancies in patients with myasthenia gravis.

Levin N, Abramsky O, Lossos A, Karussis D, Siegal T, Argov Z, Ben Hur T.

J Neurol Sci. 2005 Oct 15;237(1-2):39-43.

PMID:
15990114
7.

Thymomas and extrathymic cancers.

Weksler B, Nason KS, Mackey D, Gallagher A, Pennathur A.

Ann Thorac Surg. 2012 Mar;93(3):884-8. doi: 10.1016/j.athoracsur.2011.05.089. Epub 2011 Oct 1.

PMID:
21962262
8.

Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.

Ströbel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Rieckmann P, Nix W, Schalke B, Gold R, Müller-Hermelink HK, Peterson P, Marx A.

Ann N Y Acad Sci. 2008;1132:143-56. doi: 10.1196/annals.1405.018.

PMID:
18567864
9.

Thymoma: results of 241 operated cases.

Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E.

Ann Thorac Surg. 1991 Jan;51(1):152-6.

PMID:
1985561
10.

Surgical resection of thymoma still represents the first choice of treatment.

Ried M, Guth H, Potzger T, Diez C, Neu R, Schalke B, Hofmann HS.

Thorac Cardiovasc Surg. 2012 Mar;60(2):145-9. doi: 10.1055/s-0030-1271010. Epub 2011 Jun 20.

PMID:
21692020
11.

Different characteristics of thymomas with and without myasthenia gravis.

Yu L, Zhang XJ, Ma S, Jing Y, Li F, Krasna MJ.

Ann Surg Oncol. 2012 Jan;19(1):94-8. doi: 10.1245/s10434-011-1896-8. Epub 2011 Aug 31.

PMID:
21879277
12.

Thymoma in patients with MG: characteristics and long-term outcome.

Evoli A, Minisci C, Di Schino C, Marsili F, Punzi C, Batocchi AP, Tonali PA, Doglietto GB, Granone P, Trodella L, Cassano A, Lauriola L.

Neurology. 2002 Dec 24;59(12):1844-50.

PMID:
12503581
13.

Thymoma: prognostic factors and treatment outcomes.

Gripp S, Hilgers K, Wurm R, Schmitt G.

Cancer. 1998 Oct 15;83(8):1495-503.

PMID:
9781943
14.

Multiple thymoma with myasthenia gravis: report of a case.

Ishibashi H, Akamatsu H, Sunamori M.

Surg Today. 2003;33(1):49-51.

PMID:
12560907
15.

Second malignancy risk in patients with bronchopulmonary carcinoids: epidemiological results from Italian Network of Cancer Registries.

Lococo F, Galeone C, Sacchettini C, Leuzzi G, Cesario A, Paci M, Mangone L; AIRTUM working group contributors.

Tumori. 2017 Mar 24;103(2):e15-e20. doi: 10.5301/tj.5000598.

PMID:
28106244
16.

Clinical and pathologic predictors of survival in patients with thymoma.

Wilkins KB, Sheikh E, Green R, Patel M, George S, Takano M, Diener-West M, Welsh J, Howard S, Askin F, Bulkley GB.

Ann Surg. 1999 Oct;230(4):562-72; discussion 572-4.

17.

Thymoma is associated with an increased risk of second malignancy.

Pan CC, Chen PC, Wang LS, Chi KH, Chiang H.

Cancer. 2001 Nov 1;92(9):2406-11.

PMID:
11745297
18.

Predictors of recurrence after thymoma resection.

Bae MK, Lee CY, Lee JG, Park IK, Kim DJ, Yang WI, Chung KY.

Yonsei Med J. 2013 Jul;54(4):875-82. doi: 10.3349/ymj.2013.54.4.875.

19.

[Surgical therapy of myasthenia gravis and thymoma].

Bertram P, Treutner KH, Winkeltau G, Schumpelick V.

Chirurg. 1993 Oct;64(10):796-801. German.

PMID:
8269744
20.

[Trans-sternal thymectomy in myasthenia gravis and thymoma].

Mönig SP, Türler A, Raab M.

Zentralbl Chir. 1995;120(12):963-8. German.

PMID:
8585347

Supplemental Content

Support Center